Microbicide development: New challenges

Indian Journal of Medical Research

Volumn 123, Issue 6, 2006, Pages 719-722

  Seth, S D ^a   Sharma, Bhawna ^a   Bano, Rahmat ^a   Ganguly, N K ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPOL 974P; CARRAGEENAN; CELLACEFATE; CELLULOSE SULFATE; DAPIVIRINE; DEXTRIN; HERBACEOUS AGENT; MICROBICIDE; N [4 CHLORO 3 (3 METHYL 2 BUTENYLOXY)PHENYL] 2 METHYL 3 FURANCARBOTHIOAMIDE; POLYSTYRENESULFONIC ACID; PRANEEM; PRO 2000; SULFATE; TENOFOVIR; UNCLASSIFIED DRUG; VIVAGEL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE DISTRIBUTION; CLINICAL TRIAL; CONDOM; DRUG EFFICACY; DRUG MECHANISM; DRUG RESEARCH; DRUG SAFETY; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFECTION CONTROL; INFECTION PREVENTION; MORTALITY; PREVALENCE; SEXUALLY TRANSMITTED DISEASE; VIRUS INACTIVATION; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-INFECTIVE AGENTS; DRUG DESIGN; HUMANS; INDIA;

EID: 33747651633     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Editorial

References (13)

1. Microbicides as an option for HIV prevention. A report for the International Task Force on Global Public Goods; Stockholm; 2005 pp 17. (Webpage: http://www.gpgtaskforce.org/uploads/files/43.doc): Accessed on February 6, 2006.
2. India at a glance. Report from United Nations AIDS, Geneva. (Webpage: http://www.youandaids.org/Asia): Accessed on April 12, 2006.
3. Global Summary of the AIDS Epidemic: United Nations AIDS, Geneva, Switzerland: World Health Organization; 2005.
4. D'Cruz OJ, Uckun FM. Clinical development of microbicides for the prevention of HIV infection. Curr Pharm Des 2004; 10: 315-36.
5. Howett MK, Kuhl JP. Microbicides for prevention of transmission of sexually transmitted diseases. Curr Pharm Des 2005; 11: 3731-46.
6. Global Campaign for Microbicides. About Microbicides: The Science - Products in the Pipeline. (Webpage: http://www.global-campaign.org/ products_in_the_pipeline.htm): Accessed on February 4, 2006.
7. Wijgert JV, Coggins C. Microbicides to prevent heterosexual transmission of HIV: Ten years down the road. AIDScience 2002; 2: 23-8.
8. Joshi S, Solomon S, Mayer K, Mehendale S. Preparing for efficacy trials of vaginal microbicides in Indian women. Indian J Med Res 2005; 121: 502-9.
9. International Partnership for Microbicides (IPM), Microbicide: An Essential HIV Prevention Strategy for Achieving the Millennium Development Goals. (September, 2005). (Webpage: http://www.ipmmicrobicides.org.): Accessed on December 1, 2005.
10. Harrison PF, Rosenberg Z, Bowcut J. Topical microbicide for disease prevention: Status and challenges: HIV/AIDS. Clin Infect Dis 2003; 36: 1290-4.
11. Lard-Whiteford SL, Matecka D, O'Rear JJ, Yuen IS, Litterst C, Reichelderfer P. For the International Working Group on Microbicides. Recommendations for the Nonclinical Development of Topical Microbicides for Prevention of HIV Transmission: An Update. AIDS 2004; 36: 541-52.
12. Mauck C, Rosenberg Z, Van Damme L, For the International Working Group on microbicides. Recommendations for the Clinical Development of Topical Microbicides: an update. AIDS 2001; 15: 857-68.
13. Microbicides/Spermicides: Opportunities for Industrial Collaboration. Book Report from Family Health International; CONRAD Program. (Webpage: http://www.fhi.org/en/rh/pubs/booksreports/melconf/need.htm): Accessed on April 14, 2006.